TCL Archive In Brief: Biomedical Panel Report Will Support Cancer Program, Targeted Research January 16, 1976
TCL Archive J&J To Eliminate Its Ortho Biotech Unit As FDA Considers Further Limits On ESAs. May 2, 2008
TCL Archive Slow Accruing Trials Should Be Removed From High Priority Program, Broder Says October 2, 1992
TCL Archive In Brief: HHS Finds Fisher, Wickerham, Redmond Did Not Commit Scientific Misconduct March 7, 1997
